FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2126340219> ?p ?o ?g. }

• W2126340219 endingPage "2269" @default.
• W2126340219 startingPage "2262" @default.
• W2126340219 abstract "Background— The excess in cardiovascular risk in patients with rheumatoid arthritis provides a strong rationale for early therapeutical interventions. In view of the similarities between atherosclerosis and rheumatoid arthritis and the proven benefit of angiotensin-converting enzyme inhibitors in atherosclerotic vascular disease, it was the aim of the present study to delineate the impact of ramipril on endothelial function as well as on markers of inflammation and oxidative stress in patients with rheumatoid arthritis. Methods and Results— Eleven patients with rheumatoid arthritis were included in this randomized, double-blind, crossover study to receive ramipril in an uptitration design (2.5 to 10 mg) for 8 weeks followed by placebo, or vice versa, on top of standard antiinflammatory therapy. Endothelial function assessed by flow-mediated dilation of the brachial artery, markers of inflammation and oxidative stress, and disease activity were investigated at baseline and after each treatment period. Endothelial function assessed by flow-mediated dilation increased from 2.85±1.49% to 4.00±1.81% ( P =0.017) after 8 weeks of therapy with ramipril but did not change with placebo (from 2.85±1.49% to 2.84±2.47%; P =0.88). Although systolic blood pressure and heart rate remained unaltered, diastolic blood pressure decreased slightly from 78±7 to 74±6 mm Hg ( P =0.03). Tumor necrosis factor-α showed a significant inverse correlation with flow-mediated dilation ( r =−0.408, P =0.02), and CD40 significantly decreased after ramipril therapy ( P =0.049). Conclusions— Angiotensin-converting enzyme inhibition with 10 mg/d ramipril for 8 weeks on top of current antiinflammatory treatment markedly improved endothelial function in patients with rheumatoid arthritis. This finding suggests that angiotensin-converting enzyme inhibition may provide a novel strategy to prevent cardiovascular events in these patients." @default.
• W2126340219 created "2016-06-24" @default.
• W2126340219 creator A5013727186 @default.
• W2126340219 creator A5022674467 @default.
• W2126340219 creator A5041692742 @default.
• W2126340219 creator A5043588403 @default.
• W2126340219 creator A5045293936 @default.
• W2126340219 creator A5048531148 @default.
• W2126340219 creator A5054599182 @default.
• W2126340219 creator A5055275420 @default.
• W2126340219 creator A5055415224 @default.
• W2126340219 creator A5073770232 @default.
• W2126340219 creator A5079837121 @default.
• W2126340219 creator A5080144731 @default.
• W2126340219 creator A5082549625 @default.
• W2126340219 creator A5088939618 @default.
• W2126340219 date "2008-04-29" @default.
• W2126340219 modified "2023-10-09" @default.
• W2126340219 title "Angiotensin-Converting Enzyme Inhibition Improves Vascular Function in Rheumatoid Arthritis" @default.
• W2126340219 cites W1555489744 @default.
• W2126340219 cites W180946569 @default.
• W2126340219 cites W1964147273 @default.
• W2126340219 cites W1975393032 @default.
• W2126340219 cites W1985265801 @default.
• W2126340219 cites W1986660814 @default.
• W2126340219 cites W1989323493 @default.
• W2126340219 cites W1995407151 @default.
• W2126340219 cites W2000563697 @default.
• W2126340219 cites W2005876700 @default.
• W2126340219 cites W2010589579 @default.
• W2126340219 cites W2025016774 @default.
• W2126340219 cites W2026968003 @default.
• W2126340219 cites W2035292279 @default.
• W2126340219 cites W2038492026 @default.
• W2126340219 cites W2077741802 @default.
• W2126340219 cites W2089549133 @default.
• W2126340219 cites W2096491169 @default.
• W2126340219 cites W2098943277 @default.
• W2126340219 cites W2101978769 @default.
• W2126340219 cites W2102935782 @default.
• W2126340219 cites W2123861048 @default.
• W2126340219 cites W2129492896 @default.
• W2126340219 cites W2137499656 @default.
• W2126340219 cites W2149376299 @default.
• W2126340219 cites W2157143896 @default.
• W2126340219 cites W2160491786 @default.
• W2126340219 cites W2163046996 @default.
• W2126340219 cites W2208872067 @default.
• W2126340219 cites W2305118939 @default.
• W2126340219 cites W2309975949 @default.
• W2126340219 cites W2323216395 @default.
• W2126340219 cites W4230945318 @default.
• W2126340219 cites W4252779108 @default.
• W2126340219 cites W4301824967 @default.
• W2126340219 doi "https://doi.org/10.1161/circulationaha.107.734384" @default.
• W2126340219 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18427133" @default.
• W2126340219 hasPublicationYear "2008" @default.
• W2126340219 type Work @default.
• W2126340219 sameAs 2126340219 @default.
• W2126340219 citedByCount "102" @default.
• W2126340219 countsByYear W21263402192012 @default.
• W2126340219 countsByYear W21263402192013 @default.
• W2126340219 countsByYear W21263402192014 @default.
• W2126340219 countsByYear W21263402192015 @default.
• W2126340219 countsByYear W21263402192016 @default.
• W2126340219 countsByYear W21263402192017 @default.
• W2126340219 countsByYear W21263402192018 @default.
• W2126340219 countsByYear W21263402192019 @default.
• W2126340219 countsByYear W21263402192020 @default.
• W2126340219 countsByYear W21263402192021 @default.
• W2126340219 countsByYear W21263402192022 @default.
• W2126340219 countsByYear W21263402192023 @default.
• W2126340219 crossrefType "journal-article" @default.
• W2126340219 hasAuthorship W2126340219A5013727186 @default.
• W2126340219 hasAuthorship W2126340219A5022674467 @default.
• W2126340219 hasAuthorship W2126340219A5041692742 @default.
• W2126340219 hasAuthorship W2126340219A5043588403 @default.
• W2126340219 hasAuthorship W2126340219A5045293936 @default.
• W2126340219 hasAuthorship W2126340219A5048531148 @default.
• W2126340219 hasAuthorship W2126340219A5054599182 @default.
• W2126340219 hasAuthorship W2126340219A5055275420 @default.
• W2126340219 hasAuthorship W2126340219A5055415224 @default.
• W2126340219 hasAuthorship W2126340219A5073770232 @default.
• W2126340219 hasAuthorship W2126340219A5079837121 @default.
• W2126340219 hasAuthorship W2126340219A5080144731 @default.
• W2126340219 hasAuthorship W2126340219A5082549625 @default.
• W2126340219 hasAuthorship W2126340219A5088939618 @default.
• W2126340219 hasBestOaLocation W21263402191 @default.
• W2126340219 hasConcept C126322002 @default.
• W2126340219 hasConcept C134018914 @default.
• W2126340219 hasConcept C142724271 @default.
• W2126340219 hasConcept C164705383 @default.
• W2126340219 hasConcept C204787440 @default.
• W2126340219 hasConcept C27016395 @default.
• W2126340219 hasConcept C27081682 @default.
• W2126340219 hasConcept C2777575956 @default.
• W2126340219 hasConcept C2777604165 @default.
• W2126340219 hasConcept C2779611605 @default.

• next